| Literature DB >> 27749053 |
Nis Halland1, Jörg Czech1, Werngard Czechtizky1, Andreas Evers1, Markus Follmann1, Markus Kohlmann1, Herman A Schreuder1, Christopher Kallus1.
Abstract
Previously disclosed TAFIa inhibitors having a urea zinc-binding motif were used as the starting point for the development of a novel class of highly potent inhibitors having a sulfamide zinc-binding motif. High-resolution X-ray cocrystal structures were used to optimize the structures and reveal a highly unusual sulfamide configuration. A selected sulfamide was profiled in vitro and in vivo and displayed a promising ADMET profile.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27749053 DOI: 10.1021/acs.jmedchem.6b01276
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446